CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to PFE

disitamab vedotin

Phase 3
PFIZER (PFE)

Phase 3

Development Phase

3

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q4 '27
PFEPhase 2

Disitamab vedotin Phase 2 Est. Readout

disitamab vedotin
Q4 2027~Q
CT.gov
00%
Jan '27
PFEPhase 3

disitamab vedotin Phase 3 Est. Readout

disitamab vedotin
Jan 2027~
CT.gov
00%
Dec '26
PFEPhase 2

disitamab vedotin Phase 2 Est. Readout

disitamab vedotin
Dec 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Urothelial Carcinoma

View Full Landscape
Drug Information

Target Indication

Urothelial Carcinoma

Clinical Trial

NCT04879329

Last updated: 1/22/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.